Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
5/2022 ceased to operate
CannRx
CannRx Overview
CannRx develops proprietary science-based cannabis technologies. The company specializes in sleep and pain research, as well as on developing products for oncology support, Parkinson's disease, women's health, and recreational products for the sports industry.
The company's ican.sleep is a proprietary formulation that targets sleep disorders. The product has undergone extensive in-vivo trials in predictive pharmaceutical models. CannRx has also performed extensive in-vivo testing of a pain management formulation, which has demonstrated significant and rapid relief of pain.
CannRx's Vapor Capture Technology is an extraction technology designed specifically for the cannabis plant. The commercialized product provides a pre-activated, highly bio-available cannabis extract with a unique cannabinoid/terpene profile.
The company is also creating a patented nanoparticle technology to solubilize cannabinoids and terpenes. The process inserts the important cannabis compounds into everyday proteins, resulting in highly soluble and stable nanoparticles.
CannRx is a subsidiary of Izun Pharmaceuticals Corporation, a company in the boutique pharmaceutical area of botanical medicine.
CannRx Climate Tech relevance
undefined
Companies you might be interested in
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Sep 25, 2019
finance.yahoo.com
CannRx: The Israeli Cannabis Company Focused On Formulations, Enhanced Delivery, Extraction
#Partners #Investment #Expand
Aug 14, 2019
www.prnewswire.com
New Data Shows CannRx's CannTrap Technology Optimizes Cannabis Product Effects
#Customers #Partners
Mar 15, 2018
www.prnewswire.com
CannRx Announces Commercial Model of Vapor Capture Technology (VCT), a Revolutionary Extraction Technology Designed Specifically for the Cannabis Plant
#Customers #Partners
Mar 20, 2017
www.prnewswire.com
CannRx and iCAN:Israel-Cannabis Announce Formation of a Joint Venture to Market the First Advanced Sleep Cannabis Formulation: ican.sleep
CannRx: The Israeli Cannabis Company Focused On Formulations, Enhanced Delivery, Extraction
#Partners #Investment #Expand
Aug 14, 2019
www.prnewswire.com
New Data Shows CannRx's CannTrap Technology Optimizes Cannabis Product Effects
#Customers #Partners
Mar 15, 2018
www.prnewswire.com
CannRx Announces Commercial Model of Vapor Capture Technology (VCT), a Revolutionary Extraction Technology Designed Specifically for the Cannabis Plant
#Customers #Partners
Mar 20, 2017
www.prnewswire.com
CannRx and iCAN:Israel-Cannabis Announce Formation of a Joint Venture to Market the First Advanced Sleep Cannabis Formulation: ican.sleep
#Partners
View other companies you might be interested in
CannRx Team
No Data, yet.
Sorry, no content found under this section.
View other companies you might be interested in
Connect with
What is the reason for connecting? *
Your company *
Company website (recommended)
Please enter a valid website
Your organization type *
Please enter a valid organization type
Your position *
Add invitation message
0/300
Sending invitation...
Invitation sent
You will be able to start a conversation once [Name] accepts it.